Differentiation of MDSPCs to a neurogenic lineage prior to implantation decreases their ability to respond to environmental cues and stops transformation. by Mitra Lavasani (343357)

Population entropy in APP/PS1 mice is decreased in dCA1, but increased in vCA1. by Udaysankar Chockanathan (18510288)

KCl pulse decreased membrane, but increased nuclear, detection of NHE1 in b.End3 endothelial cells. by Erika Liktor-Busa (3328125)

Effects of CTP on CoaE enzymatic activity. by Guneet Walia (258006)

“…<p>(A), Histogram depicting the percent decrease in CoaE activity in the presence of CTP, with the activity of CoaE in the presence of ATP (1 mM) and DCoA (0.5 mM) treated as 100% (Lane 1). …”

Pretreatment of Huh-7.5.1 cells with PF-429242 results in a robust decrease in intracellular DENV-2 RNA and post-treatment of DENV-2 infected Huh-7.5.1 cells with PF-429242 impairs... by Anastasia Hyrina (3860455)

Overexpression of PDE7B increases stem cell fraction and accelerates in vivo tumor growth and decreases survival. by Michael D. Brooks (627532)

“…PDE7B-WT expression increased the clonogenic cell frequency compared to TdTomato (**indicates p = 0.001, two tailed t-test) and compared to catalytically inactive PDE7B (H217Q) (**indicates p = 0.003, two tailed t-test). …”

Exercise testing criteria to diagnose lower extremity peripheral artery disease assessed by computed-tomography angiography - Fig 2 by O. Stivalet (6890189)

“…<p><b>ROC curves of the different tests to diagnose arterial stenosis ≥ 50% in the overall population (<i>n = 126 limbs</i>)</b> (A) and in the population with an ABI > 0.91 (<i>n = 60 limbs</i>) (B). …”

Serial changes of renal function after directly acting antivirals treatment for chronic hepatitis C: A 1-year follow-up study after treatment by Shao-Ming Chiu (8707836)

“…<div><p>Background</p><p>Our preliminary data showed a slight decrease of estimated glomerular filtration rate (eGFR) after direct-acting antivirals (DAAs) treatment in chronic hepatitis C (CHC). …”

Infection decreases short chain phospholipids in the intestines of <i>V</i>. <i>cholerae</i>-infected flies. by Audrey S. Vanhove (4090594)

Fig 1 - by Hyun-Jun Kim (1561153)

“…<p>A) Chemical structure of Ni. B) Representative crystal violet assay for C2C12 myoblasts treated with Ni for 48 h (IC₅₀ = 2.11 μM). …”

Fig 6 - by Hyun-Jun Kim (1561153)

“…The IC₅₀ 3.49 μM, 2.94 μM, and 3.07 μM, respectively. ** = <i>p</i><0.01 and **** = <i>p</i><0.0001 indicate significantly decreased viability compared to the untreated control. …”

PACSIN2 is required for TcdA uptake and toxin-induced rounding in wildtype MEF cells. by Ramyavardhanee Chandrasekaran (3394916)

“…<b>(E)</b> Comparison of mean fluorescence intensities of TcdA-546 between luc and PACSIN2 siRNA transfected cells. …”

H₂ Reactions on Palladium Clusters by Adam W. Pelzer (1574233)

“…Adsorption of an H₂ molecule on Pd_<i>N</i> clusters (<i>N</i> = 2–4, 7, 13, 19, and 55) is investigated using density functional theory with the hybrid PBE0 functional. …”

5-Aza-2-deoxycytidine (5-Aza-dC) treatment does not affect methylation status of the CpG islands near to putative promoter region of both genes. by Bruna Rodrigues Muys (2588305)

Figure 3 from Ammonia Suppresses the Antitumor Activity of Natural Killer Cells and T Cells by Decreasing Mature Perforin by Joanna Domagala (21643925)

Design and Synthesis of Novel sEH Inhibitors for the Treatment of Inflammatory Bowel Disease by Huashen Xu (13987046)

“…Especially, lead compounds <b>A1</b> and <b>A9</b> showed potent inhibitory activities against sEH (<b>A1</b> and <b>A9</b>; hsEH IC₅₀ = 0.1 nM, msEH IC₅₀ = 0.1 nM). …”

Design and Synthesis of Novel sEH Inhibitors for the Treatment of Inflammatory Bowel Disease by Huashen Xu (13987046)

“…Especially, lead compounds <b>A1</b> and <b>A9</b> showed potent inhibitory activities against sEH (<b>A1</b> and <b>A9</b>; hsEH IC₅₀ = 0.1 nM, msEH IC₅₀ = 0.1 nM). …”

Design and Synthesis of Novel sEH Inhibitors for the Treatment of Inflammatory Bowel Disease by Huashen Xu (13987046)

“…Especially, lead compounds <b>A1</b> and <b>A9</b> showed potent inhibitory activities against sEH (<b>A1</b> and <b>A9</b>; hsEH IC₅₀ = 0.1 nM, msEH IC₅₀ = 0.1 nM). …”

Design and Synthesis of Novel sEH Inhibitors for the Treatment of Inflammatory Bowel Disease by Huashen Xu (13987046)

“…Especially, lead compounds <b>A1</b> and <b>A9</b> showed potent inhibitory activities against sEH (<b>A1</b> and <b>A9</b>; hsEH IC₅₀ = 0.1 nM, msEH IC₅₀ = 0.1 nM). …”

Decrease of <i>mlf</i>, <i>cwp1-3</i>, <i>myb2</i>, <i>wrky</i>, <i>pax1</i>, and <i>cdk2</i> gene expression by MLF knock down during encystation using strategy 1. by Zi-Qi Lin (6444350)

“…MLF localized to fewer MVs in the MLFko cell line relative to the control cell line. *, P <0.05 (n = 30–70 cells/condition). (E) Knock down of <i>mlf</i> gene decreased the levels of CWP1, MYB2, and other proteins in the MLFko cell line. …”